The PE Ratio as of December 2024 (TTM) for BeyondSpring Inc. (BYSI) is -4.22

According to BeyondSpring Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.22. This represents a change of -16.94% compared to the average of -5.08 of the last 4 quarters.

BeyondSpring Inc. (BYSI) Historical PE Ratio (quarterly & annually)

How has BYSI PE Ratio performed in the past?

The mean historical PE Ratio of BeyondSpring Inc. over the last ten years is -17.93. The current -4.22 PE Ratio has changed 2.25% with respect to the historical average. Over the past ten years (40 quarters), BYSI's PE Ratio was at its highest in in the September 2022 quarter at -1.31. The PE Ratio was at its lowest in in the December 2021 quarter at -4119.53.

BeyondSpring Inc. (BYSI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BeyondSpring Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BeyondSpring Inc. (BYSI) Average PE Ratio

How has BYSI PE Ratio performed in the past?

The current PE Ratio of BeyondSpring Inc. (BYSI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BeyondSpring Inc. (BYSI) PE Ratio vs. Peers

How is BYSI’s PE Ratio compared to its peers?

BeyondSpring Inc.’s PE Ratio is less than Surrozen, Inc. (-0.89), less than Armata Pharmaceuticals, Inc. (-1.78), less than Pasithea Therapeutics Corp. (-0.17), less than Oncternal Therapeutics, Inc. (-0.05), less than Aditxt, Inc. (-0.00), less than scPharmaceuticals Inc. (-1.96), less than Milestone Pharmaceuticals Inc. (-2.86), less than Oncolytics Biotech Inc. (-3.84), greater than Seres Therapeutics, Inc. (-5.75), less than aTyr Pharma, Inc. (-2.33), less than Kineta, Inc. (-0.36), greater than Candel Therapeutics, Inc. (-5.40), less than MiNK Therapeutics, Inc. (-1.52), less than Forte Biosciences, Inc. (-1.06), less than AlloVir, Inc. (-0.55), less than Ocuphire Pharma, Inc. (0), less than Reviva Pharmaceuticals Holdings, Inc. (-2.14), less than Protalix BioTherapeutics, Inc. (-1.80), greater than EyePoint Pharmaceuticals, Inc. (-13.55), less than SELLAS Life Sciences Group, Inc. (-3.85), less than null (-1.97),

Build a custom stock screener for BeyondSpring Inc. (BYSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeyondSpring Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BeyondSpring Inc. (BYSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BeyondSpring Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.